110 related articles for article (PubMed ID: 2339640)
1. Bioavailability of enteric-coated sodium fluoride tablets as affected by the administration of calcium supplements at different time intervals.
Devogelaer JP; Nagant de Deuxchaisnes C; Stein F
J Bone Miner Res; 1990 Mar; 5 Suppl 1():S75-9. PubMed ID: 2339640
[TBL] [Abstract][Full Text] [Related]
2. Comparative study of fluoride bioavailability following the administration of sodium fluoride alone and in combination with different calcium salts.
Briançon D; D'Aranda P; Quillet P; Duplan B; Chapuy MC; Arlot M; Meunier PJ
J Bone Miner Res; 1990 Mar; 5 Suppl 1():S71-3. PubMed ID: 2339639
[TBL] [Abstract][Full Text] [Related]
3. Fluoride pharmacokinetics: its implications in the fluoride treatment of osteoporosis.
Ekstrand J; Spak CJ
J Bone Miner Res; 1990 Mar; 5 Suppl 1():S53-61. PubMed ID: 2339637
[TBL] [Abstract][Full Text] [Related]
4. Intestinal absorption of fluoride preparations.
Deka RC; Kacker SK; Shambaugh GE
Laryngoscope; 1978 Dec; 88(12):1918-21. PubMed ID: 732493
[TBL] [Abstract][Full Text] [Related]
5. Influence of food and antacid administration on fluoride bioavailability from enteric-coated sodium fluoride tablets.
Arnold P; Wermeille M; Chapuy MC; Biollaz J; Grandjean EM; Schelling JL; Meunier PJ
Bone; 1989; 10(6):401-7. PubMed ID: 2624820
[TBL] [Abstract][Full Text] [Related]
6. Bioequivalence of sodium monofluorophosphate with sodium fluoride and compatibility with calcium.
Setnikar I; Maurer H
Arzneimittelforschung; 1990 Sep; 40(9):994-9. PubMed ID: 2080951
[TBL] [Abstract][Full Text] [Related]
7. Relative bioavailability of fluoride from monofluorophosphate tablets after single oral administration.
Setnikar I; Maurer H
Arzneimittelforschung; 1990 Mar; 40(3):323-8. PubMed ID: 2346544
[TBL] [Abstract][Full Text] [Related]
8. Fluoride bioavailability from slow-release sodium fluoride given with calcium citrate.
Pak CY; Sakhaee K; Parcel C; Poindexter J; Adams B; Bahar A; Beckley R
J Bone Miner Res; 1990 Aug; 5(8):857-62. PubMed ID: 2239370
[TBL] [Abstract][Full Text] [Related]
9. Intestinal absorption of fluoride at high luminal concentration of fluoride.
Rigalli A; Beinlich A; Puche RC
Arzneimittelforschung; 2001 Feb; 51(2):151-5. PubMed ID: 11258045
[TBL] [Abstract][Full Text] [Related]
10. Bioavailability and pharmacokinetic characteristics of two monofluorophosphate preparations with calcium supplement.
Setnikar I; Rovati LC; Schmid K; Vens-Cappell B; Barkworth MF
Arzneimittelforschung; 1998 Dec; 48(12):1172-8. PubMed ID: 9893933
[TBL] [Abstract][Full Text] [Related]
11. [Interactions between calcium and fluoride?].
Med Monatsschr Pharm; 1992 Jul; 15(7):214. PubMed ID: 1495447
[No Abstract] [Full Text] [Related]
12. [Fluoride bioavailability from sodium fluoride alone or in association with different calcium salts].
Brazier M; Fardelonne P; Bellony R; Sebert JL; Desmet G
Eur J Drug Metab Pharmacokinet; 1991; Spec No 3():161-5. PubMed ID: 1820871
[TBL] [Abstract][Full Text] [Related]
13. [Bioavailability study of a preparation of enteric-coated tablets of sodium fluoride (author's transl)].
Lorent M; Gervois JP; Sondagh J; Dodion L
J Pharm Belg; 1979; 34(5):272-8. PubMed ID: 512829
[No Abstract] [Full Text] [Related]
14. [Biological availability of Ossin, a sodium-fluoride dragee for osteoporosis therapy].
Becker R
Fortschr Med; 1979 Jan; 97(1):39-42. PubMed ID: 759278
[TBL] [Abstract][Full Text] [Related]
15. A single-dose, three-period, six-sequence crossover study comparing the bioavailability of solution, suspension, and enteric-coated tablets of magnesium valproate in healthy Mexican volunteers under fasting conditions.
Marcelín-Jiménez G; Angeles-Moreno AP; Contreras-Zavala L; Morales-Martínez M; Rivera-Espinosa L
Clin Ther; 2009 Sep; 31(9):2002-11. PubMed ID: 19843490
[TBL] [Abstract][Full Text] [Related]
16. Bioavailability of fluoride in postmenopausal women: comparative study between sodium fluoride and disodium monofluorophosphate-calcium carbonate.
Lioté F; Bardin C; Liou A; Brouard A; Terrier JL; Kuntz D
Calcif Tissue Int; 1992 Mar; 50(3):209-13. PubMed ID: 1617494
[TBL] [Abstract][Full Text] [Related]
17. Comparative bioavailability and in vitro characterization of two brands of diclofenac sodium enteric-coated tablets.
el-Sayed Y; Suleiman MS; Hasan M; Najib N; Muti H; Abdulhameed M
Int J Clin Pharmacol Ther Toxicol; 1988 Oct; 26(10):487-91. PubMed ID: 3235214
[TBL] [Abstract][Full Text] [Related]
18. Comparison of serum fluoride levels after administration of monofluorophosphate-calcium carbonate or sodium fluoride: differences in peak serum concentrations.
Erlacher L; Teufelsbauer H; Bernecker P; Pietschmann P; Weissel M
Clin Investig; 1994 Dec; 72(12):1082-5. PubMed ID: 7711420
[TBL] [Abstract][Full Text] [Related]
19. Effect of long-term administration of sodium fluoride on plasma calcium level in relation to intestinal absorption and urinary excretion in rabbits.
Das TK; Susheela AK
Environ Res; 1993 Jul; 62(1):14-8. PubMed ID: 8325259
[TBL] [Abstract][Full Text] [Related]
20. Comparative absorption profiles of divalproex sodium delayed-release versus extended-release tablets -- clinical implications.
Dutta S; Reed RC; O'Dea RF
Ann Pharmacother; 2006 Apr; 40(4):619-25. PubMed ID: 16569797
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
